The University of Chicago Header Logo

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ Breast Cancer. 2021 Oct 05; 7(1):131.

View in: PubMed